
The U.S. Department of Transportation (DOT) enforces strict drug and alcohol testing requirements for employees who perform safety-sensitive functions. These requirements stem from the Omnibus Transportation Employee Testing Act, implemented through 49 CFR Part 40, which mandates drug and alcohol testing across multiple transportation industries, including aviation, trucking, railroads, mass transit, and pipelines.
DOT regulations apply through the following agencies and cover a wide range of safety-sensitive positions:
From the 1950s through the 1970s, the transportation industry grew rapidly alongside consumer demand and the development of the Interstate Highway System. By the 1970s, truck driving had become a well-paid and highly visible profession, often celebrated in popular culture. During this period, the industry was heavily regulated by the government, with strict controls on pricing and where carriers were allowed to operate.
The Motor Carrier Act of 1980 reduced government regulation in the trucking industry by removing pricing controls and increasing competition. As unions declined and more carriers entered the market, shipping costs dropped, benefiting both businesses and consumers. The act also paved the way for the growth of transportation brokers and third-party logistics companies.
In the 1980s, a series of serious accidents—including the train collision in Chase, Maryland—highlighted the dangers of employee impairment. Despite opposition from some labor unions, these incidents prompted the Department of Transportation to establish strict regulations for drug and alcohol testing.
1987 Chase, Maryland Train Collision The tragedy claimed 16 lives and injured more than 160 people. Investigators found that the Conrail crew had used cannabis on duty and failed to follow critical safety signals, which directly contributed to the crash. This disaster highlighted the dangers of employee impairment in safety-sensitive jobs and led to major changes in federal regulations.
Watch: Amtrak’s Worst Disaster: The 1987 Wreck of The Colonial at Chase, MD
Watch: Ricky Gates Interview
Greatly influenced by the tragedy, the 1991 Omnibus Transportation Employee Testing Act was established. Congress expanded federal regulations to require mandatory random drug testing for all employees in safety-sensitive positions regulated by the Department of Transportation, including trucking, rail, aviation, and mass transit.
In the 2000s new drugs were assessed and moves were made to improve testing accuracy through better technology used by labs and collection sites. These became better at detecting adulterated or substituted specimen and training for collections improved.
In 2003, the DOT clarified and strengthened 49 CFR Part 40 by requiring directly observed urine collections under specific circumstances to protect the integrity of drug testing for safety-sensitive employees. Direct observation is required when there are signs of possible tampering—such as abnormal specimen temperature, evidence of adulteration, or a prior invalid test—and involves an observer visually confirming that the urine goes directly from the body into the collection container. Refusing a required observed collection is considered a refusal to test and results in immediate removal from safety-sensitive duties. These rules were implemented to prevent cheating, ensure accurate test results, and maintain public safety across DOT-regulated industries.
During the 2010s, electronic Custody and Control Forms (eCCFs) became widely adopted to reduce paperwork errors and improve tracking from specimen collection to laboratory analysis. By digitizing the process, collectors, laboratories, and employers were able to share information more efficiently, resulting in greater accuracy, faster processing, and improved overall compliance.
Click here for more information and history : DOT Drug and Alcohol Testing Program


A DOT drug test begins with a certified collector, who conducts the collection in accordance with 49 CFR §40.31 using an approved Custody and Control Form (CCF). The collector plays a critical role in maintaining test integrity by following strict procedures designed to prevent cheating, including evaluating the specimen for signs of tampering or irregularities.
The specimen is then sent to a DOT-certified laboratory, where it is analyzed for prohibited drugs in accordance with 49 CFR §40.85. The laboratory also performs specimen validity testing as required by 49 CFR §40.86(a) to determine whether the sample has been adulterated, substituted, diluted, or otherwise compromised.
Once laboratory testing is complete, the results are forwarded to a Medical Review Officer (MRO), who reviews the findings in compliance with 49 CFR §40.121. If necessary, the MRO may contact the donor to determine whether a legitimate medical explanation, such as a valid prescription, accounts for the test result.
The MRO then reports the verified final result to the employer’s Designated Employer Representative (DER). If the result is positive, the DER is required to immediately remove the employee from all safety-sensitive duties. The employee may not return to duty until completing the return-to-duty process as outlined in 49 CFR §40.23.
In addition, any employee who violates DOT drug or alcohol regulations must be evaluated by a Substance Abuse Professional (SAP) in accordance with 49 CFR §40.289. Violations include a positive test result, refusal to test, or an alcohol test result at or above the DOT threshold. The employee is prohibited from performing safety-sensitive functions until the SAP evaluation is completed and all recommended education or treatment requirements are successfully fulfilled.
What Drugs are Being Tested?
All DOT-regulated drug tests require a five-panel drug screen:

